Aucubin Inhibits Liver Cancer via HMGB1-mediated Inactivation of the PI3K/AKT/mTOR Signaling Pathway

Recent Patents on Anti-Cancer Drug Discovery · Published 2025-10-08 · DOI 10.2174/0115748928420661250922102242

Authors being retrieved — see the publisher record. https://doi.org/10.2174/0115748928420661250922102242

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

Tracing the Technological Trajectory of CAR-T Cell Therapy in Cancer Treatment through Patent Analysis · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal
Resibufogenin and Oxaliplatin Synergistically Inhibit Diffuse Gastric Cancer by Inactivating the FAK/AKT/GSK3β/β-Catenin Signaling Pathway · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal
Targeted Therapy with Dalpiciclib in a Pediatric Patient with Anaplastic Ependymoma: A Case Study and Literature Review · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal
Selenium Supplementation in Children and Adolescents Undergoing Cancer Treatment: An Analysis of the Inflammatory Profile and theExpression of Antioxidant Regulators · Recent Patents on Anti-Cancer Drug Discovery · 2026 · Same journal
A Comprehensive Review of Genistein and Chitosan: Mechanistic Foundations, Regulatory Roadmap, and Future Research Directions · Recent Patents on Anti-Cancer Drug Discovery · 2026 · Same journal
Patent Landscape and Technological Trajectory of Drug Delivery Systemsfor Overcoming Drug Resistance in Non-small Cell Lung Cancer · Recent Patents on Anti-Cancer Drug Discovery · 2026 · Same journal
L-Selenomethylselenocysteine Exerts Inhibitory Effects on the Progression of Esophageal Cancer by Targeting the PI3K/AKT Signaling Pathway · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal
MYH9 Promotes the Proliferation and Progression of Squamous Cervical Cancer Cells · Recent Patents on Anti-Cancer Drug Discovery · 2026 · Same journal
B-9-8, a Novel Harman Dimer, Reverses ABCG2-mediated Chemotherapeutic Drug Resistance · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal
Diosgenin-loaded Silver Nanoparticles: Dual Protective Role and Enhanced Radiosensitivity against ENU-induced Leukemia and γ-irradiation-inducedLiver Toxicity · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal